3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
13
Myelodysplastic Syndromes
6
Myeloproliferative Disorders
3
Leukemia, Myelomonocytic, Chronic
3
Advanced Solid Tumour
3
Small Cell Lung Carcinoma
2
Recurrence
2
Multiple Myeloma
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Advanced Breast Cancer
2
Squamous Cell Carcinoma of Head and Neck
1
Ovarian Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuroma
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Sclerosis
1
Lung Neoplasms
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Monocytic, Acute
1
Leukemia, Biphenotypic, Acute
1
Idiopathic Pulmonary Fibrosis
1
Esophageal Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Depression
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Blast Crisis
1
Interventions
Gemcitabine
13
Magnetic Resonance Spectroscopy
11
Cisplatin
9
Specimen Handling
8
pembrolizumab
6
Radiation
5
Mitomycin
5
Fluorouracil
5
Cystoscopy
5
enfortumab vedotin
4
Transurethral Resection of Bladder
4
Radiotherapy
4
Cystectomy
4
durvalumab
3
dehydroftorafur
3
avelumab
3
Platinum
3
Nivolumab
3
Mitozytrex
3
Carboplatin
3
1,2-diaminocyclohexaneplatinum II citrate
3
ulixertinib
2
tremelimumab
2
erdafitinib
2
atezolizumab
2
Radiotherapy, Intensity-Modulated
2
Radiosurgery
2
Paclitaxel
2
Immunoglobulin G
2
Docetaxel
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
Injections
×
30 days
×
Clear all
No trials found.